Evidence map›Paper›PMID 29210202›Full record

Trial reportESC heart failure2018

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.

Anna Bobenko, Inke Bartels, Marlene Münch, Tobias Trippel, Ruhdja Lindhorst, Kathleen Nolte, Christoph Herrmann-Lingen, Martin Halle, André Duvinage, Hans-Dirk Düngen and 6 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in ESC heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Highlights in heart failure.ESC heart failure · 2019
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Anna BobenkoDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Inke BartelsClinic for Cardiology and Pneumology, University of Göttingen Medical Centre, Göttingen, Germany.
Marlene MünchInstitute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Tobias TrippelDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Ruhdja LindhorstDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kathleen NolteClinic for Cardiology and Pneumology, University of Göttingen Medical Centre, Göttingen, Germany.
Christoph Herrmann-LingenDZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
Martin HalleDepartment of Prevention, Rehabilitation, and Sports Medicine, Technische Universität München, Munich, Germany.
André DuvinageDepartment of Prevention, Rehabilitation, and Sports Medicine, Technische Universität München, Munich, Germany.
Hans-Dirk DüngenDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Götz GelbrichInstitute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Carsten TschöpeDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gerd HasenfussClinic for Cardiology and Pneumology, University of Göttingen Medical Centre, Göttingen, Germany.
Rolf WachterClinic for Cardiology and Pneumology, University of Göttingen Medical Centre, Göttingen, Germany.
Burkert PieskeDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Frank EdelmannDepartment of Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
German Centre for Cardiovascular Research · DECharité - Universitätsmedizin Berlin · DETechnical University of Munich · DEUniversity of Göttingen · DEDeutsches Herzzentrum der Charité · DEZimmer Biomet (Germany) · DEZimmer Biomet (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsHeart failure with preserved ejection fraction (HFpEF) remains a common condition with no pharmacological treatment. Physical activity (PA) improves symptoms and quality of life (QoL), but no clear recommendations exist on PA in HFpEF patients. We investigated the association of PA (amount/intensity) on clinical phenotype in HFpEF. METHODS AND

resultsThe Aldosterone in Diastolic Heart Failure trial investigated spironolactone vs. placebo in stable HFpEF patients. At baseline, all patients underwent detailed phenotypization including echocardiography, cardiopulmonary exercise testing, 6 minute walking test (6MWT), and QoL assessment (36-item Short-Form questionnaire). PA was assessed by a self-report questionnaire, classified in metabolic equivalents of task (MET) and analysed with regard to exercise capacity, diastolic function, and QoL. Four hundred twenty-two patients (52% women, age 67 ± 8 years, New York Heart Association II and III) were classified by weekly MET hours into a low (<70), middle (70-140), or high (>140) level of PA. Total PA correlated positively with 6MWT distance (r = 0.17; P = 0.002) and physical function of QoL (r = 0.10; P = 0.05), but not with peak oxygen uptake (peakVO

conclusionsA higher amount of PA is related to higher submaximal exercise capacity and physical function of QoL. Regarding maximal exercise capacity, only high-intensity PA showed significant association in HFpEF patients.

Indexed as

AgedAldosteroneDouble-Blind MethodEchocardiographyExercise TherapyExercise ToleranceFemaleHeart FailureHumansMaleProspective StudiesStroke VolumeTreatment OutcomeVentricular Function, LeftAldosteroneDiastolic dysfunctionExercise capacityHeart failureHFpEFHigh intensityPhysical activity

Identifiers

PMID29210202
PMCPMC5793976
OpenAlexW2773054875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.